About Autekbio
Autekbio is a Healthcare company based in Santa Clara (United States) founded in 2006. It operates as a biopharma CDMO specializing in the production of therapeutic proteins and antibodies from mammalian cell culture. Autekbio has raised $101.03 million across 3 funding rounds from investors including Suma Capital, Beijing Capital Private Equity and Acorn Campus. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Mammalian Cell Line. Its competitors include Avid Bioservices, Bionova Scientific, Just Biotherapeutics, JHL Biotech and ProBioGen AG and 5 more; 4 of its 10 listed competitors have raised funding.
Company details
Autekbio was established in 2006 as a biopharmaceutical contract development and manufacturing organization focused on therapeutic proteins and antibodies derived from mammalian cell culture. Proprietary integrated technology platforms are utilized to deliver solutions for biopharmaceutical clients. Operations are headquartered in Santa Clara, United States, with a manufacturing facility situated in Beijings Free Trade Zone. Services encompass development and production support within the biopharma sector.
- Headquarters Santa Clara, United States
- SectorsHealthcare
- Website autekbio.com
- Social LinkedIn
- Total Equity Funding$101.03M (USD)
in 3 rounds
- Latest Funding Round$100M (USD), Private Equity Round
Mar 2010
- InvestorsSuma Capital
& 2 more
Funding Insights of Autekbio
Autekbio has successfully raised a total of $101.03M across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round of $100 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $101.03M
- Total Rounds 3
- Last Round Private Equity Round — $100M
- First Round $13,700
(Jul 2006)
- Investors Count 3
All 3 funding rounds of Autekbio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2010 | $100M | Private Equity Round | – | – | |
| Jul 2007 | $1.02M | Series A | – | – | |
| Jul 2006 | $13,700 | Seed | – | – |
3 investors in total: 3 institutional.
Investors in Autekbio
Autekbio has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Suma Capital, Beijing Capital Private Equity and Acorn Campus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Suma Capital is engaged in responsible investment management. | – | sumacapital.com | Barcelona, Spain | |
- | – | beijingcapital.org | - | |
VC and incubation firm investing in geographies such as the US and China | – | acorncampus.com | Santa Clara, United States |
Investor details for Autekbio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Autekbio
3 dated milestones of Autekbio across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Autekbio is founded.
- Funding First funding round of $14K.
- Funding Latest funding round, Private Equity Round, of $100.0M.
Competitors of Autekbio
Autekbio has 10 listed competitors in our database, 4 of them funded. They include Avid Bioservices, Bionova Scientific, Just Biotherapeutics, JHL Biotech and ProBioGen AG, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avidbio.com | 2002 | Orange, United States | – | 501 | Drug substance development, analytical, and compliance services are provided. | |
| bionovascientific.com | 2013 | Fremont, United States | $22M | 72 | Mammalian cell culture biologics are developed through contract research services. | |
| justbiotherapeutics.com | 2014 | Seattle, United States | $123.51M | 79 | Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs | |
| jhlbiotech.com | 2012 | Hsinchu, Taiwan | $186.6M | – | Contract manufacturing solutions for biologics are provided to Asian companies. | |
| probiogen.de | 1994 | Berlin, Germany | – | – | Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars | |
| polpharmabiologics.com | 2011 | Gdansk, Poland | – | – | Develops and manufactures biosimilar drugs and CDMO services for biotechnology applications. | |
| gallusbiopharma.com | 2010 | St. Louis, United States | – | – | Biologics CDMO specializing in mammalian cell line based manufacturing | |
| rentschler-biopharma.com | 1927 | Laupheim, Germany | – | 861 | Full-service CDMO for biopharmaceuticals | |
| agcbio.com | 2018 | Bothell, United States | – | 1,290 | Provides contract development and manufacturing for biopharmaceuticals worldwide. | |
| mabplexinc.com | 2013 | Yantai, China | $130M | – | Biologics development and GMP manufacturing services are offered. |
Detailed competitors of Autekbio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Autekbio (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Autekbio
Autekbio was founded in 2006.
Autekbio is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Autekbio is a funded company, having raised a total of $101.03M across 3 funding rounds to date. The company's 1st funding round was a Seed of $13.7K, raised on Jul 2006.
Autekbio was established in 2006 as a biopharmaceutical contract development and manufacturing organization focused on therapeutic proteins and antibodies derived from mammalian cell culture. Proprietary integrated technology platforms are utilized to deliver solutions for biopharmaceutical clients. Operations are headquartered in Santa Clara, United States, with a manufacturing facility situated in Beijings Free Trade Zone. Services encompass development and production support within the biopharma sector.
Autekbio's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.
Autekbio has 3 investors. Key investors include Suma Capital, Beijing Capital Private Equity, and Acorn Campus.